Amyris rises on workforce reduction plan, CEO resignation
** Shares of biotech firm Amyris AMRS.O rise as much as
7.3% to $1.18; Stock last up ~4%
** Co to implement workforce reduction to cut costs
** Also, CEO John Melo steps down from his role and from the
board, effective immediately
** AMRS appoints Han Kieftenbeld as interim executive chief
** Stock has fallen over 24% so far in 2023
(Reporting by Anne Florentyna Gnanaraja Sekar in Bengaluru)
((AnneFlorentyna.GnanarajaSekar@thomsonreuters.com;))
Recent news on Amyris
See all newsBrief: Amyris Announces Kathy Fortmann As New CEO
Brief: Amyris Announced Termination Or Separation Of About 80 Employees on Feb 7
Brief: Amyris- Related To Sale Of Some Consumer Brands, Announces Termination/ Separation Of About 220 Employees
Brief: Amyris On December 12, Debtors Entered Into An Amendment To And Restatement Of That Certain Plan Support Agreement, Dated October 12, 2023
Brief: Amyris Inc On August 10, Received Notice Of Delisting From Nasdaq